<!DOCTYPE article
PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN" "JATS-archivearticle1-3-mathml3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="1.3" xml:lang="en" article-type="research-article"><?properties open_access?><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Cureus</journal-id><journal-id journal-id-type="iso-abbrev">Cureus</journal-id><journal-id journal-id-type="issn">2168-8184</journal-id><journal-title-group><journal-title>Cureus</journal-title></journal-title-group><issn pub-type="epub">2168-8184</issn><publisher><publisher-name>Cureus</publisher-name><publisher-loc>Palo Alto (CA)</publisher-loc></publisher></journal-meta>
<article-meta><article-id pub-id-type="pmc">PMC11681943</article-id><article-id pub-id-type="doi">10.7759/cureus.74688</article-id><article-categories><subj-group subj-group-type="heading"><subject>Pediatric Surgery</subject></subj-group><subj-group><subject>Cardiac/Thoracic/Vascular Surgery</subject></subj-group></article-categories><title-group><article-title>Short-Term Surgical Outcomes and Definitive Diagnosis in Patients With Congenital Cardiac Defects: A Single-Center Analysis</article-title></title-group><contrib-group><contrib contrib-type="editor"><name><surname>Muacevic</surname><given-names>Alexander</given-names></name></contrib><contrib contrib-type="editor"><name><surname>Adler</surname><given-names>John R</given-names></name></contrib></contrib-group><contrib-group><contrib contrib-type="author" corresp="yes"><name><surname>Aasim</surname><given-names>Muhammad</given-names></name><xref rid="aff-1" ref-type="aff">1</xref></contrib><contrib contrib-type="author"><name><surname>Aziz</surname><given-names>Raheela</given-names></name><xref rid="aff-2" ref-type="aff">2</xref></contrib><contrib contrib-type="author"><name><surname>Mohsin</surname><given-names>Atta ul</given-names></name><xref rid="aff-1" ref-type="aff">1</xref></contrib><contrib contrib-type="author"><name><surname>Khan</surname><given-names>Raheel</given-names></name><xref rid="aff-1" ref-type="aff">1</xref></contrib><contrib contrib-type="author"><name><surname>Zahid</surname><given-names>Ayesha</given-names></name><xref rid="aff-2" ref-type="aff">2</xref></contrib><contrib contrib-type="author"><name><surname>Ikram</surname><given-names>Jibran</given-names></name><xref rid="aff-2" ref-type="aff">2</xref></contrib></contrib-group><aff id="aff-1">
<label>1</label>
Cardiac Surgery, Hayatabad Medical Complex Peshawar, Peshawar, PAK </aff><aff id="aff-2">
<label>2</label>
Cardiovascular Medicine, Hayatabad Medical Complex Peshawar, Peshawar, PAK </aff><author-notes><corresp id="cor1">
Muhammad Aasim <email>doctoraasim@yahoo.com</email>
</corresp></author-notes><pub-date date-type="pub" publication-format="electronic"><day>28</day><month>11</month><year>2024</year></pub-date><pub-date date-type="collection" publication-format="electronic"><month>11</month><year>2024</year></pub-date><volume>16</volume><issue>11</issue><elocation-id>e74688</elocation-id><history><date date-type="accepted"><day>28</day><month>11</month><year>2024</year></date></history><permissions><copyright-statement>Copyright &#x000a9; 2024, Aasim et al.</copyright-statement><copyright-year>2024</copyright-year><copyright-holder>Aasim et al.</copyright-holder><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This is an open access article distributed under the terms of the Creative Commons Attribution License CC-BY 4.0., which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</license-p></license></permissions><self-uri xlink:href="https://www.cureus.com/articles/318621-short-term-surgical-outcomes-and-definitive-diagnosis-in-patients-with-congenital-cardiac-defects-a-single-center-analysis">This article is available from https://www.cureus.com/articles/318621-short-term-surgical-outcomes-and-definitive-diagnosis-in-patients-with-congenital-cardiac-defects-a-single-center-analysis</self-uri><abstract><p>Background</p><p>With the rising number of children with congenital heart disease (CHD) reaching adulthood, surgical intervention has become a critical aspect of their long-term management. This study presents a six-year overview of early postoperative outcomes and mortality in CHD surgeries at a single center, underscoring advancements and challenges in treating this complex population.</p><p>Objective</p><p>As more children with CHD&#x000a0;grow into adulthood, we are gaining critical insights from our extensive experience in performing cardiac surgery for this population. This report details our six-year experience at a single center, highlighting short-term outcomes and in-hospital mortality rates.</p><p>Methods</p><p>We collected data on all consecutive patients with CHD&#x000a0;who underwent surgery between July 2018 and September 2024 in the Cardiac Surgery Department at Hayatabad Medical Complex, Peshawar, Pakistan. We evaluated early outcomes, including ventilation duration, length of intensive care unit (ICU) stay, total hospital stay, and mortality rates.</p><p>Results</p><p>A total of 250 procedures were performed on patients, with a mean age of 22.98 years (Range 1-78 years); 48.4% were male and 51.6% were female. Re-do procedures accounted for 2.4% of the total procedures. The most common procedures involved repair of septal defects (43.8%), right heart lesions (19.2%), and thoracic arterial and venous surgeries (16.8%). While the primary procedures&#x000a0;involved less complex cases, they included 15.2% tetralogy of Fallot repairs, 4.0% aortic coarctation repairs, and 1.2% repairs for Ebstein&#x02019;s disease. In-hospital mortality was recorded at 1.6%, with an overall survival rate of 98.4%.</p><p>Conclusion</p><p>Surgery in patients with CHD can be performed with low operative mortality and favorable clinical outcomes. Our findings demonstrate that, despite the complexities inherent to this population, most procedures yield successful results, contributing to a high overall survival rate. This underscores the importance of specialized surgical approaches and continuous management for CHD patients, emphasizing the potential for positive long-term outcomes in this growing demographic.</p></abstract><kwd-group kwd-group-type="author"><kwd>cardiac surgery</kwd><kwd>congenital heart disease</kwd><kwd>septal defects</kwd><kwd>short term outcome</kwd><kwd>surgical outcomes</kwd></kwd-group></article-meta></front><body><sec sec-type="intro"><title>Introduction</title><p>Congenital heart disease (CHD) is the most prevalent birth defect, affecting approximately one in every 100 live births [<xref rid="REF1" ref-type="bibr">1</xref>]. In the United States, the incidence of CHD&#x000a0;among premature infants, excluding isolated patent ductus arteriosus (PDA) and atrial septal defect (ASD), is 12.5 cases per 1,000 live births [<xref rid="REF2" ref-type="bibr">2</xref>]. Despite improvements in detection and treatment, CHD still contributes to 3% of all infant deaths and 46% of fatalities resulting from congenital malformations [<xref rid="REF3" ref-type="bibr">3</xref>]. The first successful surgical intervention for CHD, known as patent ductus arteriosus (PDA)&#x000a0;ligation, was carried out by Dr. Robert Gross in 1938. Surgical procedures for other conditions were introduced over the following three to four decades. The survival outlook for patients with CHD&#x000a0;has significantly improved in recent decades, primarily due to earlier diagnosis and advancements in surgical and percutaneous techniques tailored for this population [<xref rid="REF4" ref-type="bibr">4</xref>]. Surgery performed at a younger age is primarily life-saving, whereas cardiac procedures performed later in life are typically elective and aim to alleviate symptoms or enhance prognosis. Today, about 90% of children born with CHD&#x000a0;are reaching adulthood [<xref rid="REF5" ref-type="bibr">5</xref>,<xref rid="REF6" ref-type="bibr">6</xref>]. Due to significant advancements in pediatric cardiology, cardiac surgery, and intensive care, individuals with critical and complex CHD&#x000a0;can now successfully reach adulthood. The surgical management of CHD&#x000a0;in adults has experienced substantial growth recently, likely driven by a combination of improved diagnostic and treatment techniques, as well as increased patient awareness [<xref rid="REF7" ref-type="bibr">7</xref>,<xref rid="REF8" ref-type="bibr">8</xref>]. Some individuals with CHD&#x000a0;may undergo primary surgery for defects that were either not treated in childhood or not detected early. Others might need reoperations after corrective surgeries or additional palliative procedures following an initial intervention [<xref rid="REF9" ref-type="bibr">9</xref>]. Factors that affect outcomes are reduced myocardial function, decreased vascular compliance, increased arrhythmias, dysfunction of other organ systems, and age-associated comorbidities [<xref rid="REF10" ref-type="bibr">10</xref>]. In this study, we aim to share our experiences and results over a six-year period at a single center, highlighting short-term outcomes and in-hospital mortality rates.</p></sec><sec sec-type="materials|methods"><title>Materials and methods</title><p>After institutional research and ethical board approval, we collected the data retrospectively on all patients who underwent CHD at a single tertiary care center, Hayatabad Medical Complex, Peshawar, Pakistan; between July 1, 2018&#x000a0;and September 30, 2024. Data regarding patient demographics, diagnoses, cardiac surgical procedures, and outcome parameters were gathered from the medical records. Collected data included ventricular function measured by ejection fraction (EF) by echocardiography, which was classified as either impaired (EF &#x0003c; 50%) or preserved (EF &#x0003e; 50%).&#x000a0;A diagnosis of diabetes was considered present if there was a documented prior diagnosis. Pulmonary hypertension (PHT) was categorized based on systolic pulmonary artery pressure as: mild (less than 40 mmHg), moderate (between 40 mmHg to 60 mmHg), and severe (greater than 60 mmHg). The outcomes were predefined as the duration of mechanical ventilation, the lengths of stay in the intensive care unit (ICU) and the hospital, as well as in-hospital mortality. Statistical analysis was conducted using SPSS version 20 (IBM Corp., Armonk, NY, USA). Descriptive statistics for continuous variables are reported as mean and standard deviation and categorical variables are summarized as n (%).</p><p>Institutional Review Board approval was taken from Medical Teaching Institute-Hayatabad Medical Complex with the approval number 2303.</p></sec><sec sec-type="results"><title>Results</title><p>During the study period, a total of 250 patients underwent&#x000a0;initial surgery or a reoperation for CHD. Among the 250 patients,&#x000a0;121 were males (48.4%) and 129 females (51.6%) (Figure <xref rid="FIG1" ref-type="fig">1</xref>).&#x000a0;</p><fig position="anchor" fig-type="figure" id="FIG1"><label>Figure 1</label><caption><title>Gender distribution of patients undergoing congenital heart disease surgery (n=250)</title></caption><graphic xlink:href="cureus-0016-00000074688-i01" position="float"/></fig><p>The preoperative assessment of the patient cohort revealed significant insights into their cardiac health. Of the 250 patients evaluated, 234 (93.6%) exhibited preserved ventricular function, while 16 (6.4%) had impaired function. In terms of pulmonary hypertension, 153 (61.2%) were classified as having normal levels, whereas 52 (20.8%) experienced mild, 36 (14.4%) had moderate, and nine (3.6%) had severe hypertension. Additionally, comorbid conditions included diabetes in 22 (8.8%), active endocarditis in 16 (6.4%), and a prior cardiac surgery in six (2.4%). These findings highlight the diversity of preoperative conditions among the patients, which could impact surgical outcomes and influence postoperative care strategies (Table <xref rid="TAB1" ref-type="table">1</xref>).</p><table-wrap position="float" id="TAB1"><label>Table 1</label><caption><title>Main characteristics of congenital heart disease (CHD) patients.</title></caption><table frame="hsides" rules="groups"><tbody><tr style="background-color:#ccc"><td rowspan="1" colspan="1">Variables</td><td rowspan="1" colspan="1">Number (%)</td></tr><tr><td rowspan="1" colspan="1">Sex</td><td rowspan="1" colspan="1">&#x000a0;</td></tr><tr style="background-color:#ccc"><td rowspan="1" colspan="1">&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0; Male</td><td rowspan="1" colspan="1">121 (48.4%)</td></tr><tr><td rowspan="1" colspan="1">&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0; Female</td><td rowspan="1" colspan="1">129 (51.6%)</td></tr><tr style="background-color:#ccc"><td rowspan="1" colspan="1">Age (In years)</td><td rowspan="1" colspan="1">&#x000a0;</td></tr><tr><td rowspan="1" colspan="1">&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0; Mean &#x000b1; SD</td><td rowspan="1" colspan="1">22.98 &#x000b1; 15.38</td></tr><tr style="background-color:#ccc"><td rowspan="1" colspan="1">&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0; &#x000a0;Range</td><td rowspan="1" colspan="1">1-78</td></tr><tr><td rowspan="1" colspan="1">Ventricular function:</td><td rowspan="1" colspan="1">&#x000a0;</td></tr><tr style="background-color:#ccc"><td rowspan="1" colspan="1">&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0; Preserved&#x000a0;</td><td rowspan="1" colspan="1">234 (93.6%)</td></tr><tr><td rowspan="1" colspan="1">&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0; Impaired</td><td rowspan="1" colspan="1">16 (6.4%)</td></tr><tr style="background-color:#ccc"><td rowspan="1" colspan="1">Pulmonary hypertension:</td><td rowspan="1" colspan="1">&#x000a0;</td></tr><tr><td rowspan="1" colspan="1">&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0; Normal</td><td rowspan="1" colspan="1">153 (61.2%)&#x000a0;</td></tr><tr style="background-color:#ccc"><td rowspan="1" colspan="1">&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0; Mild</td><td rowspan="1" colspan="1">52 (20.8%)&#x000a0; &#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;</td></tr><tr><td rowspan="1" colspan="1">&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0; Moderate</td><td rowspan="1" colspan="1">36 (14.4%)</td></tr><tr style="background-color:#ccc"><td rowspan="1" colspan="1">&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0; Severe</td><td rowspan="1" colspan="1">9 (3.6%)</td></tr><tr><td rowspan="1" colspan="1">Diabetes</td><td rowspan="1" colspan="1">22 (8.8%)</td></tr><tr style="background-color:#ccc"><td rowspan="1" colspan="1">Active Endocarditis&#x000a0;</td><td rowspan="1" colspan="1">16 (6.4%)</td></tr><tr><td rowspan="1" colspan="1">Previous Cardiac surgery</td><td rowspan="1" colspan="1">6 (2.4%)</td></tr></tbody></table></table-wrap><p>The average duration of ventilation was 7.33 &#x000b1; 5.964 hours, length of stay in the ICU was&#x000a0;41.34 &#x000b1; 8.291 hours and average hospital&#x000a0;stay was 5.14 &#x000b1; 0.662 days (Table <xref rid="TAB2" ref-type="table">2</xref>).</p><table-wrap position="float" id="TAB2"><label>Table 2</label><caption><title>Perioperative parameters (early outcomes). </title><p>ICU: intensive care unit, SD: standard deviation.</p></caption><table frame="hsides" rules="groups"><tbody><tr style="background-color:#ccc"><td rowspan="1" colspan="1">Variables</td><td rowspan="1" colspan="1">Mean &#x000b1; SD&#x000a0;</td></tr><tr><td rowspan="1" colspan="1">Ventilation (hours)&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;</td><td rowspan="1" colspan="1">7.33 &#x000b1; 5.964</td></tr><tr style="background-color:#ccc"><td rowspan="1" colspan="1">ICU Stay (hours)&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;</td><td rowspan="1" colspan="1">41.34 &#x000b1; 8.291&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;</td></tr><tr><td rowspan="1" colspan="1">Hospital Stay (days)</td><td rowspan="1" colspan="1">5.14 &#x000b1; 0.662</td></tr><tr style="background-color:#ccc"><td rowspan="1" colspan="1">In Hospital mortality (N)%-</td><td rowspan="1" colspan="1">4 (1.6%)</td></tr></tbody></table></table-wrap><p>The definitive diagnoses of patients in our study encompassed a range of CHD. Among septal defects, 75 patients (30%) had secundum ASD, while six (2.4%) had sinus venosus ASD, and 21 (8.4%) presented with ventricular septal defects (VSD). Additionally, there was one (0.4%) case of partial ASD and two (0.8%) cases of complete atrioventricular septal defect.</p><p>Right heart lesions included 38 patients (15.2%) with Tetralogy of Fallot, three (1.2%) with Ebstein&#x02019;s disease, and seven (2.8%) with pulmonary atresia associated with VSD. Thoracic anomalies featured 10 patients (4.0%) with aortic coarctation and 31 (12.4%) with PDA.</p><p>Electrophysiologic conditions included congenital heart block in 11 patients (4.4%), while pulmonary venous anomalies comprised one (0.4%) case of partial anomalous pulmonary venous connection and two (0.8%) cases of total anomalous pulmonary venous connection.</p><p>Lastly, left heart lesions included eight patients (3.2%) with subaortic stenosis. Additionally, several combinations of conditions were identified among the patients. Specifically, five patients (2.0%) had both ventricular septal defect and PDA, while three patients (1.2%) had ventricular septal defect with aortic stenosis.</p><p>Furthermore, four patients (1.6%) presented with ventricular septal defect and aortic regurgitation, and another five patients (2.0%) had ventricular septal defect alongside coronary artery disease. ASD was also noted in combination with various conditions: seven patients (2.8%) had severe tricuspid regurgitation, four (1.6%) had mitral regurgitation, and three (1.2%) had severe mitral stenosis.</p><p>Additionally, one patient (0.4%) presented with ASD and left atrial myxoma, while another patient (0.4%) had ASD combined with PDA. These findings illustrate the complexity of CHD in the cohort (Figure <xref rid="FIG2" ref-type="fig">2</xref>, Table <xref rid="TAB3" ref-type="table">3</xref>).</p><fig position="anchor" fig-type="figure" id="FIG2"><label>Figure 2</label><caption><title>Definitive diagnosis</title><p>ASD: Atrial septal defect, LA: Left atrium, VSD: Ventricular septal defect, PDA: Patent ductus arteriosus, TAPV: Total Anomalous pulmonary venous connection, PAPVC: Partial anomalous pulmonary venous connection, TOF: Tetralogy of Fallot&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0;&#x000a0;</p></caption><graphic xlink:href="cureus-0016-00000074688-i02" position="float"/></fig><table-wrap position="float" id="TAB3"><label>Table 3</label><caption><title>Primary anatomic diagnosis </title><p>PA:&#x000a0;Persistent arteriosus, LA: Left atrium, VSD: Ventricular septal defect, PDA: Patent ductus arteriosus, TOF: Tetralogy of Fallot&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;</p></caption><table frame="hsides" rules="groups"><tbody><tr style="background-color:#ccc"><td rowspan="1" colspan="1">Definitive Diagnosis</td><td rowspan="1" colspan="1">Number (%)</td></tr><tr><td rowspan="1" colspan="1">Septal defects</td><td rowspan="1" colspan="1">&#x000a0;</td></tr><tr style="background-color:#ccc"><td rowspan="1" colspan="1">- Atrial septal defect, secundum</td><td rowspan="1" colspan="1">75 (30%)</td></tr><tr><td rowspan="1" colspan="1">- Atrial septal defect, sinus venosus</td><td rowspan="1" colspan="1">6 (2.4%)</td></tr><tr style="background-color:#ccc"><td rowspan="1" colspan="1">- Ventricular septal defect</td><td rowspan="1" colspan="1">21 (8.4%)</td></tr><tr><td rowspan="1" colspan="1">- Atrio-ventricular septal defect, partial</td><td rowspan="1" colspan="1">1 (0.4%)</td></tr><tr style="background-color:#ccc"><td rowspan="1" colspan="1">- Atrio-ventricular septal defect, complete</td><td rowspan="1" colspan="1">2 (0.8%)</td></tr><tr><td rowspan="1" colspan="1">Right heart lesions</td><td rowspan="1" colspan="1">&#x000a0;</td></tr><tr style="background-color:#ccc"><td rowspan="1" colspan="1">- Tetralogy of Fallot</td><td rowspan="1" colspan="1">38 (15.2%)</td></tr><tr><td rowspan="1" colspan="1">- Ebstein&#x02019;s disease</td><td rowspan="1" colspan="1">3 (1.2%)</td></tr><tr style="background-color:#ccc"><td rowspan="1" colspan="1">- Pulmonary atresia, VSD including TOF/PA</td><td rowspan="1" colspan="1">7 (2.8%)</td></tr><tr><td rowspan="1" colspan="1">Thoracic arteries &#x00026; veins</td><td rowspan="1" colspan="1">&#x000a0;</td></tr><tr style="background-color:#ccc"><td rowspan="1" colspan="1">- Aortic coarctation</td><td rowspan="1" colspan="1">10 (4.0%)</td></tr><tr><td rowspan="1" colspan="1">- Coronary artery anomaly, origin</td><td rowspan="1" colspan="1">1 (0.4%)</td></tr><tr style="background-color:#ccc"><td rowspan="1" colspan="1">- Patent ductus arteriosus</td><td rowspan="1" colspan="1">31 (12.4%)</td></tr><tr><td rowspan="1" colspan="1">Electrophysiologic</td><td rowspan="1" colspan="1">&#x000a0;</td></tr><tr style="background-color:#ccc"><td rowspan="1" colspan="1">- Arrhythmia, heart block, congenital</td><td rowspan="1" colspan="1">11 (4.4%)</td></tr><tr><td rowspan="1" colspan="1">Pulmonary venous anomalies</td><td rowspan="1" colspan="1">&#x000a0;</td></tr><tr style="background-color:#ccc"><td rowspan="1" colspan="1">- Partial anomalous pulmonary venous connection</td><td rowspan="1" colspan="1">1 (0.4%)</td></tr><tr><td rowspan="1" colspan="1">- Total Anomalous pulmonary venous connection</td><td rowspan="1" colspan="1">2 (0.8%)</td></tr><tr style="background-color:#ccc"><td rowspan="1" colspan="1">Left heart lesion</td><td rowspan="1" colspan="1">&#x000a0;</td></tr><tr><td rowspan="1" colspan="1">- Subaortic membrane (subaortic stenosis)</td><td rowspan="1" colspan="1">8 (3.2%)</td></tr><tr style="background-color:#ccc"><td rowspan="1" colspan="1">Others</td><td rowspan="1" colspan="1">&#x000a0;</td></tr><tr><td rowspan="1" colspan="1">- Ventricular septal defect + PDA</td><td rowspan="1" colspan="1">5 (2.0%)</td></tr><tr style="background-color:#ccc"><td rowspan="1" colspan="1">- Ventricular septal defect + Aortic stenosis</td><td rowspan="1" colspan="1">3 (1.2%)</td></tr><tr><td rowspan="1" colspan="1">- Ventricular septal defect + Aortic regurgitation</td><td rowspan="1" colspan="1">4 (1.6%)</td></tr><tr style="background-color:#ccc"><td rowspan="1" colspan="1">- Ventricular septal defect + Coronary artery disease</td><td rowspan="1" colspan="1">5 (2.0%)</td></tr><tr><td rowspan="1" colspan="1">- Atrial septal defect + Severe Tricuspid regurgitation</td><td rowspan="1" colspan="1">7 (2.8%)</td></tr><tr style="background-color:#ccc"><td rowspan="1" colspan="1">- Atrial septal defect + Mitral regurgitation</td><td rowspan="1" colspan="1">4 (1.6%)</td></tr><tr><td rowspan="1" colspan="1">- Atrial septal defect + Severe Mitral stenosis</td><td rowspan="1" colspan="1">3 (1.2%)</td></tr><tr style="background-color:#ccc"><td rowspan="1" colspan="1">- Atrial septal defect + LA myxoma</td><td rowspan="1" colspan="1">1 (0.4%)</td></tr><tr><td rowspan="1" colspan="1">- Atrial septal defect + PDA</td><td rowspan="1" colspan="1">1 (0.4%)</td></tr></tbody></table></table-wrap><p>Septal defect repairs included 75 cases (30%) of secundum ASD repair, six cases (2.4%) of sinus venosus ASD repair, and 21 cases (8.4%) of VSD repair. Additionally, there were one (0.4%) partial and two (0.8%) complete atrioventricular septal defect repairs. Right heart lesions were addressed with three (1.2%) Ebstein&#x02019;s repairs and 38 (15.2%) total corrections for tetralogy of Fallot (TOF). Left heart lesions were treated&#x000a0;with eight (3.2%) subaortic membrane resections. Electrophysiologic procedures included 11 patients (4.4%) receiving pacemakers. Thoracic interventions consisted of 10 cases (4.0%) of end-to-end coarctation repair, 31 (12.4%) PDA closures, and one (0.4%) coronary artery bypass for anomalous origin. Palliative care involved seven (2.8%) central shunt procedures. Lastly, pulmonary venous anomalies were treated with one (0.4%) repair of partial anomalous pulmonary venous connection and two (0.8%) repairs of total anomalous pulmonary venous connection. These procedures reflect the diverse surgical management in our patient population. Surgical procedures performed on patients with congenital heart defects are outlined in Table <xref rid="TAB4" ref-type="table">4</xref>.</p><table-wrap position="float" id="TAB4"><label>Table 4</label><caption><title>Procedures performed on patients with congenital heart defects. </title><p>PDA: Patent ductus arteriosus</p></caption><table frame="hsides" rules="groups"><tbody><tr style="background-color:#ccc"><td rowspan="1" colspan="1">Main Surgeries</td><td rowspan="1" colspan="1">Number (%) (n=250)</td></tr><tr><td rowspan="1" colspan="1">Septal Defects</td><td rowspan="1" colspan="1">&#x000a0;</td></tr><tr style="background-color:#ccc"><td rowspan="1" colspan="1">- Atrial septal defect Secundum repair</td><td rowspan="1" colspan="1">75 (30%)</td></tr><tr><td rowspan="1" colspan="1">- Atrial septal defect Sinus venosus repair</td><td rowspan="1" colspan="1">6 (2.4%)</td></tr><tr style="background-color:#ccc"><td rowspan="1" colspan="1">- Ventricular septal defect repair</td><td rowspan="1" colspan="1">21 (8.4%)</td></tr><tr><td rowspan="1" colspan="1">- Partial atrioventricular septal defect repair</td><td rowspan="1" colspan="1">1 (0.4%)</td></tr><tr style="background-color:#ccc"><td rowspan="1" colspan="1">- Complete atrioventricular septal defect repair</td><td rowspan="1" colspan="1">2 (0.8%)</td></tr><tr><td rowspan="1" colspan="1">Right Heart Lesions</td><td rowspan="1" colspan="1">&#x000a0;</td></tr><tr style="background-color:#ccc"><td rowspan="1" colspan="1">- Ebstein&#x02019;s repair</td><td rowspan="1" colspan="1">3 (1.2%)</td></tr><tr><td rowspan="1" colspan="1">- Total correction for Tetralogy of Fallot</td><td rowspan="1" colspan="1">38 (15.2%)</td></tr><tr style="background-color:#ccc"><td rowspan="1" colspan="1">Electrophysiologic</td><td rowspan="1" colspan="1">&#x000a0;</td></tr><tr><td rowspan="1" colspan="1">- Pacemaker procedure</td><td rowspan="1" colspan="1">11 (4.4%)</td></tr><tr style="background-color:#ccc"><td rowspan="1" colspan="1">Thoracic Arteries &#x00026; Veins</td><td rowspan="1" colspan="1">&#x000a0;</td></tr><tr><td rowspan="1" colspan="1">- Coarctation repair, end-to-end</td><td rowspan="1" colspan="1">10 (4.0%)</td></tr><tr style="background-color:#ccc"><td rowspan="1" colspan="1">- PDA closure</td><td rowspan="1" colspan="1">31 (12.4%)</td></tr><tr><td rowspan="1" colspan="1">- Coronary artery bypass for anomalous origin of coronary artery</td><td rowspan="1" colspan="1">1 (0.4%)</td></tr><tr style="background-color:#ccc"><td rowspan="1" colspan="1">Palliative Procedures</td><td rowspan="1" colspan="1">&#x000a0;</td></tr><tr><td rowspan="1" colspan="1">- Shunt, central</td><td rowspan="1" colspan="1">7 (2.8%)</td></tr><tr style="background-color:#ccc"><td rowspan="1" colspan="1">Pulmonary Venous Anomalies</td><td rowspan="1" colspan="1">&#x000a0;</td></tr><tr><td rowspan="1" colspan="1">- Partial anomalous pulmonary venous connection repair</td><td rowspan="1" colspan="1">1 (0.4%)</td></tr><tr style="background-color:#ccc"><td rowspan="1" colspan="1">- Total anomalous pulmonary venous connection repair</td><td rowspan="1" colspan="1">2 (0.8%)</td></tr><tr><td rowspan="1" colspan="1">Left Heart Lesions</td><td rowspan="1" colspan="1">&#x000a0;</td></tr><tr style="background-color:#ccc"><td rowspan="1" colspan="1">- Subaortic membrane resection</td><td rowspan="1" colspan="1">8 (3.2%)</td></tr></tbody></table></table-wrap><p>A total of 33 surgical interventions (13.2%) involved various combinations of procedures. A total of five patients (2.0%) underwent VSD closure along with PDA ligation, while three patients (1.2%) received both VSD closure and aortic valve replacement. Additionally, four patients (1.6%) had VSD closure combined with aortic valve repair, and another five patients (2.0%) underwent VSD closure with coronary artery bypass grafting. For ASD procedures, seven patients (2.8%) had closure combined with tricuspid valve repair, four patients (1.6%) had closure with mitral valve repair, and three patients (1.2%) underwent closure with mitral valve replacement. Furthermore, one patient (0.4%) had ASD closure along with left atrial myxoma resection, and another patient (0.4%) received closure combined with PDA ligation (Table <xref rid="TAB5" ref-type="table">5</xref>).</p><table-wrap position="float" id="TAB5"><label>Table 5</label><caption><title>Concomitant procedures.</title><p>ASD: Atrial septal defect, LA: Left atrium, VSD: Ventricular septal defect, PDA: Patent ductus arteriosus</p></caption><table frame="hsides" rules="groups"><tbody><tr style="background-color:#ccc"><td rowspan="1" colspan="1">Surgeries</td><td rowspan="1" colspan="1">Number (%)</td></tr><tr><td rowspan="1" colspan="1">VSD closure + PDA ligation</td><td rowspan="1" colspan="1">5 (2.0%)</td></tr><tr style="background-color:#ccc"><td rowspan="1" colspan="1">VSD closure + Aortic valve replacement</td><td rowspan="1" colspan="1">3 (1.2%)</td></tr><tr><td rowspan="1" colspan="1">VSD closure + Aortic valve repair</td><td rowspan="1" colspan="1">4 (1.6%)</td></tr><tr style="background-color:#ccc"><td rowspan="1" colspan="1">VSD closure + Coronary artery bypass grafting</td><td rowspan="1" colspan="1">5(2.0%) &#x000a0;</td></tr><tr><td rowspan="1" colspan="1">ASD closure + Tricuspid valve repair</td><td rowspan="1" colspan="1">7(2.8%) &#x000a0;</td></tr><tr style="background-color:#ccc"><td rowspan="1" colspan="1">ASD closure + Mitral valve repair</td><td rowspan="1" colspan="1">4 (1.6%)</td></tr><tr><td rowspan="1" colspan="1">ASD closure + Mitral valve replacement</td><td rowspan="1" colspan="1">3 (1.2%)</td></tr><tr style="background-color:#ccc"><td rowspan="1" colspan="1">ASD closure + LA myxoma resection</td><td rowspan="1" colspan="1">1 (0.4%)</td></tr><tr><td rowspan="1" colspan="1">ASD closure + Patent ductus arteriosus ligation</td><td rowspan="1" colspan="1">1 (0.4%)</td></tr></tbody></table></table-wrap><p>These combinations reflect the complexity of surgical management in this patient population. In our study, six (2.4%) patients underwent surgery as a redo for congenital heart defects that had been primarily addressed during childhood (Table <xref rid="TAB1" ref-type="table">1</xref>).</p></sec><sec sec-type="discussion"><title>Discussion</title><p>Outcomes following CHD&#x000a0;surgeries have significantly improved over recent decades due to advances in surgical techniques, anesthesia, and perioperative care. Our six years of experience, encompassing over 250 procedures for patients with CHD&#x000a0;in a specialized adult cardiac surgery department, provides a valuable foundation for reflecting on and strategizing healthcare for this unique patient population in&#x000a0;Pakistan. Advancements in diagnostic tools and enhanced medical management have enabled most newborns with CHDs to reach adulthood. However, only those with relatively simple conditions, such as isolated VSD, PDA without pulmonary hypertension, or ASD, are typically cured through primary cardiac surgery [<xref rid="REF11" ref-type="bibr">11</xref>]. Consequently, the short- and long-term outcomes of adults with CHD have emerged as a crucial area of growing clinical interest. In the present era, patient presentations, in Pakistan, show considerable variation. Some individuals undergo primary surgery for defects that were not addressed during childhood, whether due to lack of recognition or missed follow-up. Meanwhile, others require redo surgeries to address complications arising from previous palliative procedures. In our study, the redo procedures primarily originated from other cities in Pakistan or neighboring Afghanistan, with the exception of one case of total correction for TOF that had previously undergone a palliative procedure at our center. A palliative procedure was proposed for the patients with complex CHD, aiming to temporarily enhance their clinical condition. While these palliative operations such as central shunts effectively reduced cyanosis with a relatively low hospital mortality rate of 0% in our study. Overall, we recorded six redo cases, in-hospital mortality rate was 4%, which is comparable to findings from studies conducted at tertiary care centers specializing in adult congenital heart surgery, such as the one by Niwa et al. [<xref rid="REF12" ref-type="bibr">12</xref>]. When we compare our results to those of larger multicenter studies, early mortality rates are notably low, falling between 1.7% and 3.1%. Our study indicates an overall survival rate of 98.4%, which is favorable for corrective procedures. In our study, the average length of stay and ventilation duration were notably short, and well comparable with findings from other research [<xref rid="REF11" ref-type="bibr">11</xref>,<xref rid="REF13" ref-type="bibr">13</xref>]. None of the patients in the study required chest re-exploration due to bleeding. We conducted this study to assess short-term outcomes in&#x000a0;patients with CHD. Our findings demonstrate favorable mortality and survival rates that are comparable to those from various centers worldwide. Given the increasing diversity within this patient population, it is essential for researchers and clinical teams to intensify their efforts to address patient needs and enhance their quality of life.</p><p>This study has some limitations, as a single-center&#x000a0;analysis, the findings may not be generalizable to all CHD centers, especially those with different patient demographics or resource limitations. Future prospective studies across multiple centers are recommended to validate these findings and explore long-term outcomes.</p></sec><sec sec-type="conclusions"><title>Conclusions</title><p>Our findings on surgery for CHD suggest that low mortality and minimal serious morbidity can be achieved at a tertiary referral center. However, further research is needed to explore key areas such as decision-making for this patient population, the optimal timing for interventions, and the development of more accurate predictive models, especially considering the diverse range of anatomical diagnoses and surgical procedures involved. Despite these positive outcomes, continued efforts are necessary to extend access to CHD care and resources, especially in underserved areas, to ensure that all CHD patients, regardless of geography, can benefit from these advancements. Future multi-center, long-term studies are warranted to further elucidate factors impacting morbidity and survival in adult CHD populations, especially as they age and acquire additional comorbidities.</p></sec></body><back><fn-group content-type="conflict"><title>Disclosures</title><fn fn-type="COI-statement"><p><bold>Human subjects:</bold> Consent for treatment and open access publication was obtained or waived by all participants in this study. Institutional Research Ethics Board of Medical Teaching Institute-Hayatabad Medical Complex issued approval 2303.</p><p><bold>Animal subjects:</bold> All authors have confirmed that this study did not involve animal subjects or tissue.</p><p><bold>Conflicts of interest:</bold> In compliance with the ICMJE uniform disclosure form, all authors declare the following:</p><p><bold>Payment/services info:</bold> All authors have declared that no financial support was received from any organization for the submitted work.</p><p><bold>Financial relationships:</bold> All authors have declared that they have no financial relationships at present or within the previous three years with any organizations that might have an interest in the submitted work.</p><p><bold>Other relationships:</bold> All authors have declared that there are no other relationships or activities that could appear to have influenced the submitted work.</p></fn></fn-group><fn-group content-type="other"><title>Author Contributions</title><fn fn-type="other"><p><bold>Concept and design:</bold>&#x000a0; Muhammad Aasim, Raheela Aziz, Atta ul Mohsin, Raheel Khan, Ayesha Zahid, Jibran Ikram</p><p><bold>Acquisition, analysis, or interpretation of data:</bold>&#x000a0; Muhammad Aasim, Raheela Aziz, Atta ul Mohsin, Raheel Khan, Ayesha Zahid, Jibran Ikram</p><p><bold>Drafting of the manuscript:</bold>&#x000a0; Muhammad Aasim, Raheela Aziz, Atta ul Mohsin, Raheel Khan, Ayesha Zahid, Jibran Ikram</p><p><bold>Critical review of the manuscript for important intellectual content:</bold>&#x000a0; Muhammad Aasim, Raheela Aziz, Atta ul Mohsin, Raheel Khan, Ayesha Zahid, Jibran Ikram</p><p><bold>Supervision:</bold>&#x000a0; Muhammad Aasim</p></fn></fn-group><ref-list><title>References</title><ref id="REF1"><label>1</label><element-citation publication-type="journal"><article-title>The incidence of congenital heart disease</article-title><source>J Am Coll Cardiol</source><person-group>
<name><surname>Hoffman</surname><given-names>JI</given-names></name>
<name><surname>Kaplan</surname><given-names>S</given-names></name>
</person-group><fpage>1890</fpage><lpage>1900</lpage><volume>39</volume><year>2002</year><pub-id pub-id-type="pmid">12084585</pub-id>
</element-citation></ref><ref id="REF2"><label>2</label><element-citation publication-type="journal"><article-title>Congenital cardiac disease in the newborn infant: past, present, and future</article-title><source>Crit Care Nurs Clin North Am</source><person-group>
<name><surname>Sadowski</surname><given-names>SL</given-names></name>
</person-group><fpage>37</fpage><lpage>0</lpage><page-range>37-48, vi</page-range><volume>21</volume><year>2009</year><pub-id pub-id-type="pmid">19237042</pub-id>
</element-citation></ref><ref id="REF3"><label>3</label><element-citation publication-type="journal"><article-title>Newborn screening for congenital heart defects: a systematic review and cost-effectiveness analysis</article-title><source>Health Technol Assess</source><person-group>
<name><surname>Knowles</surname><given-names>R</given-names></name>
<name><surname>Griebsch</surname><given-names>I</given-names></name>
<name><surname>Dezateux</surname><given-names>C</given-names></name>
<name><surname>Brown</surname><given-names>J</given-names></name>
<name><surname>Bull</surname><given-names>C</given-names></name>
<name><surname>Wren</surname><given-names>C</given-names></name>
</person-group><fpage>1</fpage><lpage>0</lpage><page-range>1-152, iii-iv</page-range><volume>9</volume><year>2005</year></element-citation></ref><ref id="REF4"><label>4</label><element-citation publication-type="journal"><article-title>Survival prospects and circumstances of death in contemporary adult congenital heart disease patients under follow-up at a large tertiary centre</article-title><source>Circulation</source><person-group>
<name><surname>Diller</surname><given-names>GP</given-names></name>
<name><surname>Kempny</surname><given-names>A</given-names></name>
<name><surname>Alonso-Gonzalez</surname><given-names>R</given-names></name>
<etal/>
</person-group><fpage>2118</fpage><lpage>2125</lpage><volume>132</volume><year>2015</year><pub-id pub-id-type="pmid">26369353</pub-id>
</element-citation></ref><ref id="REF5"><label>5</label><element-citation publication-type="journal"><article-title>Task force 1: the changing profile of congenital heart disease in adult life</article-title><source>J Am Coll Cardiol</source><person-group>
<name><surname>Warnes</surname><given-names>C</given-names></name>
<name><surname>Liberthson</surname><given-names>R</given-names></name>
<name><surname>Danielson</surname><given-names>G</given-names></name>
<etal/>
</person-group><fpage>1170</fpage><lpage>1175</lpage><volume>37</volume></element-citation></ref><ref id="REF6"><label>6</label><element-citation publication-type="journal"><article-title>Temporal trends in survival to adulthood among patients born with congenital heart disease from 1970 to 1992 in Belgium</article-title><source>Circulation</source><person-group>
<name><surname>Moons</surname><given-names>P</given-names></name>
<name><surname>Bovijn</surname><given-names>L</given-names></name>
<name><surname>Budts</surname><given-names>W</given-names></name>
<name><surname>Belmans</surname><given-names>A</given-names></name>
<name><surname>Gewillig</surname><given-names>M</given-names></name>
</person-group><fpage>2264</fpage><lpage>2272</lpage><volume>122</volume><year>2010</year><pub-id pub-id-type="pmid">21098444</pub-id>
</element-citation></ref><ref id="REF7"><label>7</label><element-citation publication-type="journal"><article-title>Delivery of care for adult patients with congenital heart disease in Europe: results from the Euro Heart Survey</article-title><source>Eur Heart J</source><person-group>
<name><surname>Moons</surname><given-names>P</given-names></name>
<name><surname>Engelfriet</surname><given-names>P</given-names></name>
<name><surname>Kaemmerer</surname><given-names>H</given-names></name>
<name><surname>Meijboom</surname><given-names>FJ</given-names></name>
<name><surname>Oechslin</surname><given-names>E</given-names></name>
<name><surname>Mulder</surname><given-names>BJ</given-names></name>
</person-group><fpage>1324</fpage><lpage>1330</lpage><volume>27</volume><year>2006</year><pub-id pub-id-type="pmid">16641110</pub-id>
</element-citation></ref><ref id="REF8"><label>8</label><element-citation publication-type="journal"><article-title>Prevalence of congenital heart disease</article-title><source>Am Heart J</source><person-group>
<name><surname>Hoffman</surname><given-names>JI</given-names></name>
<name><surname>Kaplan</surname><given-names>S</given-names></name>
<name><surname>Liberthson</surname><given-names>RR</given-names></name>
</person-group><fpage>425</fpage><lpage>439</lpage><volume>147</volume><year>2004</year><pub-id pub-id-type="pmid">14999190</pub-id>
</element-citation></ref><ref id="REF9"><label>9</label><element-citation publication-type="journal"><article-title>The care of adult patients with congenital heart defects: a new challenge</article-title><source>Ital Heart J</source><person-group>
<name><surname>Chessa</surname><given-names>M</given-names></name>
<name><surname>Cullen</surname><given-names>S</given-names></name>
<name><surname>Deanfield</surname><given-names>J</given-names></name>
<etal/>
</person-group><fpage>178</fpage><lpage>182</lpage><volume>5</volume><year>2004</year><uri xlink:href="https://pubmed.ncbi.nlm.nih.gov/15119499/">https://pubmed.ncbi.nlm.nih.gov/15119499/</uri><pub-id pub-id-type="pmid">15119499</pub-id>
</element-citation></ref><ref id="REF10"><label>10</label><element-citation publication-type="journal"><article-title>Risk factors and early outcomes of multiple reoperations in adults with congenital heart disease</article-title><source>Ann Thorac Surg</source><person-group>
<name><surname>Holst</surname><given-names>KA</given-names></name>
<name><surname>Dearani</surname><given-names>JA</given-names></name>
<name><surname>Burkhart</surname><given-names>HM</given-names></name>
<name><surname>Connolly</surname><given-names>HM</given-names></name>
<name><surname>Warnes</surname><given-names>CA</given-names></name>
<name><surname>Li</surname><given-names>Z</given-names></name>
<name><surname>Schaff</surname><given-names>HV</given-names></name>
</person-group><fpage>122</fpage><lpage>128</lpage><volume>92</volume><year>2011</year><pub-id pub-id-type="pmid">21718837</pub-id>
</element-citation></ref><ref id="REF11"><label>11</label><element-citation publication-type="journal"><article-title>Outcomes in adult congenital heart surgery: analysis of the Society of Thoracic Surgeons database</article-title><source>J Thorac Cardiovasc Surg</source><person-group>
<name><surname>Mascio</surname><given-names>CE</given-names></name>
<name><surname>Pasquali</surname><given-names>SK</given-names></name>
<name><surname>Jacobs</surname><given-names>JP</given-names></name>
<name><surname>Jacobs</surname><given-names>ML</given-names></name>
<name><surname>Austin EH</surname><given-names>3rd</given-names></name>
</person-group><fpage>1090</fpage><lpage>1097</lpage><volume>142</volume><year>2011</year><pub-id pub-id-type="pmid">21911232</pub-id>
</element-citation></ref><ref id="REF12"><label>12</label><element-citation publication-type="journal"><article-title>Survey of specialized tertiary care facilities for adults with congenital heart disease</article-title><source>Int J Cardiol</source><person-group>
<name><surname>Niwa</surname><given-names>K</given-names></name>
<name><surname>Perloff</surname><given-names>JK</given-names></name>
<name><surname>Webb</surname><given-names>GD</given-names></name>
<name><surname>Murphy</surname><given-names>D</given-names></name>
<name><surname>Liberthson</surname><given-names>R</given-names></name>
<name><surname>Warnes</surname><given-names>CA</given-names></name>
<name><surname>Gatzoulis</surname><given-names>MA</given-names></name>
</person-group><fpage>211</fpage><lpage>216</lpage><volume>96</volume><year>2004</year><pub-id pub-id-type="pmid">15262035</pub-id>
</element-citation></ref><ref id="REF13"><label>13</label><element-citation publication-type="journal"><article-title>National practice patterns for management of adult congenital heart disease: operation by pediatric heart surgeons decreases in-hospital death</article-title><source>Circulation</source><person-group>
<name><surname>Karamlou</surname><given-names>T</given-names></name>
<name><surname>Diggs</surname><given-names>BS</given-names></name>
<name><surname>Person</surname><given-names>T</given-names></name>
<name><surname>Ungerleider</surname><given-names>RM</given-names></name>
<name><surname>Welke</surname><given-names>KF</given-names></name>
</person-group><fpage>2345</fpage><lpage>2352</lpage><volume>118</volume><year>2008</year><pub-id pub-id-type="pmid">18997167</pub-id>
</element-citation></ref></ref-list></back></article>